Kenvue Stock (NYSE:KVUE)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$21.61

52W Range

$17.67 - $24.46

50D Avg

$22.90

200D Avg

$20.87

Market Cap

$41.74B

Avg Vol (3M)

$14.30M

Beta

1.26

Div Yield

$0.81 (3.72%)

KVUE Company Profile


Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

Show More

Industry

Household & Personal Products

Sector

Consumer Defensive

Exchange

NYSE

ADR

-

Country

US

Employees

22,000

IPO Date

May 04, 2023

Website

KVUE Performance


KVUE Financial Summary


Dec 23Dec 22Dec 21
Revenue$15.44B$14.95B$15.05B
Operating Income$2.50B$2.67B$2.92B
Net Income$1.66B$2.09B$2.03B
EBITDA$3.13B$3.35B$3.85B
Basic EPS$0.90$1.10$1.08
Diluted EPS$0.90$1.10$1.08

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 07, 24 | 11:09 AM
Q2 24Aug 06, 24 | 2:25 PM
Q1 24May 07, 24 | 1:22 PM